RUS  ENG
Full version
PEOPLE

Novikov Fedor Nikolaevich

Publications in Math-Net.Ru

  1. How to stop worrying and love multiple citation experimental data

    Mendeleev Commun., 35:2 (2025),  224–227
  2. Reducing false-positive rates in virtual screening via cancellation of systematic errors in the scoring function

    Mendeleev Commun., 32:6 (2022),  735–738
  3. Modeling of novel CDK7 inhibitors activity by molecular dynamics and free energy perturbation methods

    Mendeleev Commun., 30:4 (2020),  430–432
  4. Molecular foundations of COVID-19 pathogenesis

    Usp. Khim., 89:8 (2020),  858–878
  5. Charge redistribution in the SpnF-catalyzed Diels–Alder reaction

    Mendeleev Commun., 27:5 (2017),  500–502
  6. Modeling comparative selectivity profiles of kinase inhibitors using FEP/MD protocol

    Mendeleev Commun., 27:4 (2017),  349–351
  7. Exhaustive conformational search for transition states: the case of catechol O-methyltransferase active site

    Mendeleev Commun., 27:3 (2017),  224–227
  8. Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro

    Mendeleev Commun., 25:5 (2015),  364–366
  9. Modeling of the Diels–Alder reaction enantioselectivity by quantum mechanics and molecular mechanics

    Mendeleev Commun., 25:4 (2015),  269–270
  10. Efficacy of Novel Syk-Kinase Inhibitors MT-SYK-03 and MT-SYK-322 in Cellular Models of Autoimmunity and Cancer

    Mendeleev Commun., 22:6 (2012),  287–289
  11. Rational design and synthesis of novel Syk-kinase inhibitors

    Mendeleev Commun., 22:2 (2012),  73–74
  12. Rational design and synthesis of new PARP1 inhibitors

    Mendeleev Commun., 22:1 (2012),  15–17
  13. Novel fragment-like inhibitors of EphA2 obtained by experimental screening and modelling

    Mendeleev Commun., 20:5 (2010),  263–265
  14. Molecular docking: theoretical background, practical applications and perspectives

    Mendeleev Commun., 19:5 (2009),  237–242


© Steklov Math. Inst. of RAS, 2026